These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36765517)

  • 1. [Research Progress of Long Non-Coding RNA in Hematological Tumors --Review].
    Li F; Yang FF; Xu YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):306-310. PubMed ID: 36765517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research Progress on Long Non-Coding RNA in Hematological Malignancies--Review].
    Xin LY; Zhong SS; Liu AF; Chen YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):237-40. PubMed ID: 26913428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of long non-coding RNAs in hematologic malignancies].
    Hu WL; Gao A
    Yi Chuan; 2015 Nov; 37(11):1095-104. PubMed ID: 26582523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
    Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNAs in blood cells: Roles in cell development and potential pathogenesis in hematological malignancies.
    Guan X; Sun Y; Zhang C
    Crit Rev Oncol Hematol; 2022 Dec; 180():103849. PubMed ID: 36261116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.
    Zhong X; Lü M; Wan J; Zhou T; Qin B
    Biomed Pharmacother; 2018 Nov; 107():382-389. PubMed ID: 30099342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway.
    Wang X; Yang J; Guo G; Feng R; Chen K; Liao Y; Zhang L; Sun L; Huang S; Chen JL
    Mol Cancer; 2019 Apr; 18(1):84. PubMed ID: 30961617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs in normal and malignant hematopoiesis.
    Nobili L; Lionetti M; Neri A
    Oncotarget; 2016 Aug; 7(31):50666-50681. PubMed ID: 27177333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncogenic role of SAMMSON lncRNA in tumorigenesis: A comprehensive review with especial focus on melanoma.
    Ghasemian M; Babaahmadi-Rezaei H; Khedri A; Selvaraj C
    J Cell Mol Med; 2023 Dec; 27(24):3966-3973. PubMed ID: 37772815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
    Peng W; Fan H
    Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy.
    Huang Z; Wang Z; Xia H; Ge Z; Yu L; Li J; Bao H; Liang Z; Cui Y; Xu Y
    Clin Chim Acta; 2023 Jan; 539():162-169. PubMed ID: 36528049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of non-coding RNAs in hematological malignancies.
    Ghafouri-Fard S; Esmaeili M; Taheri M
    Eur J Pharmacol; 2020 May; 875():172976. PubMed ID: 32112777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DUXAP8: A Promising lncRNA with Carcinogenic Potential in Cancer.
    Wang B; Xu W; Cai Y; Chen J; Guo C; Zhou G; Yuan C
    Curr Med Chem; 2022; 29(10):1677-1686. PubMed ID: 34313198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear Enriched Abundant Transcript 1 (NEAT1): A long non-coding RNA with diverse functions in tumorigenesis.
    Ghafouri-Fard S; Taheri M
    Biomed Pharmacother; 2019 Mar; 111():51-59. PubMed ID: 30576934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of lncRNA AFAP1-AS1 correlates with poor prognosis and promotes tumorigenesis in colorectal cancer.
    Wang F; Ni H; Sun F; Li M; Chen L
    Biomed Pharmacother; 2016 Jul; 81():152-159. PubMed ID: 27261589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma.
    Feng H; Zhang X; Lai W; Wang J
    Cell Cycle; 2020 Jul; 19(13):1641-1653. PubMed ID: 32450050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution and underlying mechanisms of lncRNA TRPM2-AS in the development and progression of human cancers.
    Li F; Chen X
    Pathol Res Pract; 2023 Nov; 251():154887. PubMed ID: 37871443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research Progress on miR-125 Family in Malignant Hematologic Diseases-Review].
    Liu AF; Wang JX; Li FL; Chen YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1842-1846. PubMed ID: 29262928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis.
    Zhang M; Wang W; Li T; Yu X; Zhu Y; Ding F; Li D; Yang T
    Biomed Pharmacother; 2016 May; 80():73-79. PubMed ID: 27133041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.